Emergency contraception in the iPLEDGE program: A cross‐sectional survey of pediatric dermatology provider understanding and practice. Issue 5 (2nd August 2022)

• Record Type: Journal Article
• Authors: Smiley, Catherine E.; Butt, Melissa; Zaenglein, Andrea L.
• Is Part Of: Pediatric dermatology. Volume 39:Issue 5(2022)
• Page Start: 727
• Page End: 730
• Publication Date: 2022-08-02
• Subjects: accutane -- contraception -- emergency contraception -- iPLEDGE -- isotretinoin -- REMS; Pediatric dermatology -- Periodicals; Children -- Diseases -- Periodicals; 618.925
• DOI: 10.1111/pde.15086
• Languages: English
• ISSNs: 0736-8046

Abstract

Abstract: For patients with acne treated with the teratogen isotretinoin, emergency contraception (EC) is the only recourse when abstinence fails or effective contraception is not properly used. The purpose of this study was to evaluate the current understanding and provision of EC among pediatric dermatology providers. The survey found that 37% (21/57) of providers indicated they were at least somewhat confident in their understanding of EC. 7% (4/57) of providers agreed/strongly agreed that they provided EC counseling to all patients of reproductive potential at their initial visit and 3.5% (2/57) agreed/strongly agreed that they provide EC counseling at follow‐up visits. Our survey results suggest the need for improved EC education for pediatric dermatology providers and subsequent counseling for patients of reproductive potential on isotretinoin therapy.